CD272 Polyclonal Antibody,China/Abbkine_specification/price/image

Product Detail
Company Profile

BTLA encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in BTLA have been associated with an increased risk of rheumatoid arthritis. BTLA (B And T Lymphocyte Associated) is a Protein Coding gene. Diseases associated with BTLA include Xanthogranulomatous Cholecystitis. Among its related pathways are T Cell Co-Signaling Pathway: Ligand-Receptor Interactions and Class I MHC mediated antigen processing and presentation.

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC-p 1:50-200, ELISA 1:10000-20000.

CD272 Polyclonal Antibody product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at https://www.abbkine.com/product/cd272-polyclonal-antibody-abp58052/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.